Multicentric carpotarsal osteolysis syndrome (MCTO) is a rare disease characterized by progressive osteolysis in the wrist and forearm, with potential involvement of other bone structures. It is manifested by pain, swelling, and limited joint mobility. MCTO belongs to the group of autosomal dominant diseases and is usually observed in young people. It is important to note that this disease occurs as a result of pathological changes in bone metabolism, which leads to the destruction of bone structure. The clinical picture includes not only osteolysis, but also the possible development of osteopenia and osteoporosis, which makes the disease much more difficult to diagnose and treat.
History of the disease and interesting historical facts
Multicentric carpotarsal osteolysis syndrome was first described at the beginning of the 21st century. In 2005, a paper was published in which scientists recorded several cases of this disease in patients who had no predisposition to injuries or other diseases leading to osteolysis. Later, in 2011, research revealed a link between this syndrome and mutations in genes responsible for bone tissue support. Today, the main focus of scientific circles is on studying the pathogenesis and heredity of this disease, as well as developing more effective diagnostic and treatment methods.
Epidemiology
Epidemiological studies show that the syndrome of multicentric carpotarsal osteolysis occurs in the population with a frequency of 1 per 1,000,000 people. It is most often diagnosed in young people aged 15 to 30 years. The nosological group of this disease most often includes such patients as athletes working in conditions of increased stress on the hands. It is statistically confirmed that women suffer from this disease 1.5 times more often than men. However, it should be noted that many cases remain unreported due to undiagnosed and complex clinical picture.
Genetic predisposition to this disease
Genetic predisposition to multicentric carpotarsal osteolysis syndrome is associated with mutations in genes responsible for cartilage and bone tissue function. The most studied gene is the gene encoding osteopetdin (OPG), which plays a key role in regulating osteoclastic activity. Research shows that mutations in OPG can lead to an imbalance between bone formation and destruction, which in turn causes osteolysis. Geneticists have also attracted the attention of other involved genes, such as RANK and RANKL, which regulate bone resorption.
Risk factors for the development of this disease
Risk factors for multicentric carpotarsal osteolysis syndrome include:
- Heredity: presence of cases of MCO in the family history.
- Intense physical activity: professional and sports activities with high load on the hands and wrists.
- Certain chemical exposures: working with toxic substances that promote the destruction of bone tissue.
- Age: the disease is more common in young people and rare in the elderly.
Thus, the complex of factors predisposing to the disease makes its study particularly relevant, especially given the growing popularity of extreme sports and increasing life expectancy.
Diagnosis of this disease
Diagnosis of multicentric carpotarsal osteolysis syndrome is based on a combination of clinical manifestations, laboratory and radiological examination methods. The main symptoms include:
- Pain in the wrist and palm area.
- Swelling of the joints.
- Limited joint mobility.
To confirm the diagnosis, the following studies are carried out:
- Laboratory tests: blood tests for markers of inflammation and osteolysis.
- Radiological examinations: X-rays and MRI to visualize osteolysis and soft tissue condition.
- Bone biopsy: In rare cases, this may be needed to rule out other diseases.
- Differential diagnosis: exclusion of osteoporosis, osteomalacia and other diseases causing osteolysis.
Thus, a comprehensive approach to diagnostics allows for timely detection of the disease and development of a treatment plan.
Treatment
Treatment of multicentric carpotarsal osteolysis syndrome requires an individual approach and may include both conservative and surgical methods. General approaches to treatment:
- Pharmacological treatment: use of anti-inflammatory and analgesic drugs to relieve symptoms.
- Surgical treatment: In some cases, surgery to correct bone damage or arthroplasty may be needed.
- Physiotherapy: rehabilitation after surgery or to restore joint function.
- Use of biological drugs: According to recent studies, the use of antibodies to RANKL may improve the condition of patients.
The difficulty lies in the fact that ICC requires a long-term and comprehensive approach, taking into account the characteristics of each patient.
List of medications used to treat this disease
Medications used to treat multicentric carpotarsal osteolysis syndrome include:
- Ibuprofen – to reduce pain and inflammation.
- Diclofenac – to control inflammatory processes.
- Bisphosphonates – to enhance bone mineralization.
- Antibodies to RANKL are in experimental stages and clinical trials.
Each of the listed remedies must be prescribed by a doctor, taking into account the patient’s age and stage of the disease.
Disease monitoring
Monitoring the condition of patients with multicentric carpotarsal osteolysis syndrome includes regular check-ups and observations, which allows for treatment adjustments and disease course prognosis. Control stages:
- Regular visits to the doctor to assess the clinical condition.
- Repeated laboratory tests to analyze bone markers.
- Rational use of instrumental examination methods, such as MRI or radiography.
The prognosis of the disease may vary depending on the stage of the lesion. Complications may include chronic pain, limited mobility, and the need for surgical intervention.
Age-related features of the disease
Multicentric carpotarsal osteolysis syndrome manifests itself differently in different age groups. In younger patients, the disease is often accompanied by pronounced clinical symptoms and rapid development of osteolysis. In older patients, it may occur with less pronounced symptoms, but is associated with an increased risk of complications such as osteoporosis and fractures. Thus, age-related features impose additional requirements for diagnosis and treatment, which makes it a particularly important aspect of the overall patient management strategy.
Questions and Answers
- What is multicentric carpotarsal osteolysis syndrome? This is a rare condition characterized by osteolysis in the wrist area, resulting in pain and limited movement.
- What are the main symptoms of the disease? Wrist pain, swelling and limited joint mobility.
- How is the disease diagnosed? Diagnosis includes clinical examinations, radiography, MRI and biochemical tests.
- What treatment methods are used? Treatment can be conservative (physiotherapy, pharmacology) or surgical, depending on the stage of the disease.
- What is the prognosis for this disease? The prognosis depends on the stage: early diagnosis and treatment increase the chances of improvement.
